Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The membrane attack complex of complement causes severe demyelination associated with acute axonal injury.
[Current therapy of multiple sclerosis].
Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.
Immunology of neuromyelitis optica: a T cell-B cell collaboration.
The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS).
Consensus recommendations for the diagnosis and treatment of multiple sclerosis in Kuwait.
Neuromyelitis optica in Portugal (NEMIPORT) - A multicentre study.
Fampridine improves severe dysarthria in secondary-progressive multiple sclerosis.
[Disease modifying drugs in multiple sclerosis and pregnancy.]
Disease-modifying drugs for multiple sclerosis must be globally available according to therapeutic guidelines suitable to different regions of the world.
Activities of the European multiple sclerosis platform.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Differential aspects of immune cell infiltration and neurodegeneration in acute and relapse experimental autoimmune encephalomyelitis.
Neurobehavioral and cytotoxic effects of vanadium during oligodendrocyte maturation: A protective role for erythropoietin.
Health effects of lesion localization in multiple sclerosis: spatial registration and confounding adjustment.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Cognitive functions in multiple sclerosis: impact of gray matter integrity.
The diagnosis of multiple sclerosis and the various related demyelinating syndromes: A critical review.
[Charcot-Marie-Tooth disease associated with periaxin mutations (CMT4F): Clinical, electrophysiological and genetic analysis of 24 patients.]
The risk of cancer from azathioprine as a treatment for multiple sclerosis.
Lysophospholipids and their receptors in the central nervous system.
[Clinical epidemiology of multiple sclerosis in Moscow. Discriptive epidemiology in population of one region of Moscow.]
Regulatory B Cells in Experimental Autoimmune Encephalomyelitis (EAE).
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.
Pages
« first
‹ previous
…
399
400
401
402
403
404
405
406
407
…
next ›
last »